Tradestie Institutional Equity Comparison Engine

BMRA vs BNBX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BMRA Overall Edge

BMRA Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biomerica Inc (BMRA) driven by superior Growth & Margin, Momentum & Technical while BNBX counters with relative strength in Valuation. Fundamentally, BMRA trades at N/M Forward P/E with -125.2% operating margin (-8.3% YoY revenue) versus BNBX at N/M Forward P/E and -636.4% operating margin (+34.3% YoY). In options structure, BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BNBX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner BNBX
BMRA N/M vs BNBX N/M Fwd P/E
Growth & Margin Winner BMRA
Op Margin -125.2% vs -636.4% ยท YoY -8.3% vs +34.3%
Momentum & Technical Winner BMRA
1Y -45.6% vs -97.0% ยท 52W Pos 5% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BMRA NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.36
+0.0% 1D
Market Cap $6.0M
1M Return -26.49%
1Y Return -45.6%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 44.0
BNBX US Equity
BNB Plus Corp.
Finance Services
$0.16
-56.75% 1D
Market Cap $2.7M
1M Return -67.4%
1Y Return -96.95%
Forward P/E N/M
Unified AI Score
37.7 / 100 SELL
Tech 40.0 Fund 46.0 Flow 50.0 Mom 48.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BMRA -45.6% BNBX -96.95% Spread: +62.36 pp (BMRA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period BMRA Revenue BNBX Revenue BMRA Op. Margin BNBX Op. Margin Margin Edge
FY2019 $10M $10M -46.4% -169.3% BMRA
FY2020 $10M $0M -41.0% -649.0% BMRA
FY2021 $10M $10M -104.2% -147.9% BMRA
FY2022 $20M $20M -24.0% -76.9% BMRA
FY2023 $10M $10M -135.3% -81.9% BNBX
FY2024 $10M $0M -117.6% -646.7% BMRA
FY2025 $10M $0M -96.7% -750.9% BMRA
FY2026 $0M N/A -119.5% N/A BMRA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BMRA (5) vs BNBX (2)
Institutional Metric BMRA BNBX Criterion Row Winner
Market Capitalization Scale $6.0M $2.7M Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -8.3% +34.3% Higher Growth BNBX
Operating Margin (TTM) Profitability -125.2% -636.4% Higher Margin BMRA
Net Profit Margin Profitability -115.5% 0.0% Higher Margin BNBX
Return on Equity (ROE) Capital Efficiency -113.8% -306.8% Higher ROE BMRA
52-Week Range Position Momentum 5% ($1โ€“$3) 0% ($0โ€“$7) Stronger Trend BMRA
Beta / 30D Volatility Risk Regime 0.67ฮฒ ยท 62% Vol 1.68ฮฒ ยท 227% Vol Lower Realized Risk BMRA
Unified Institutional Score Composite Signal 44.5 / 100 (HOLD) 37.7 / 100 (SELL) Higher Composite BMRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BMRA vs BNBX Buy Guide
BMRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BMRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BNBX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BNBX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BMRA nor BNBX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.